Effects of elcatonin on bone mass of postmenopausal Chinese women with osteoporosis

被引：0
|
作者：
Meng, XW
Xing, XP
Xia, WB
Zhang, ZHW
Qing, MW
Yu, W
Tian, JP
Zhou, XY
机构：
[1] BEIJING UNION MED COLL HOSP,CHINESE ACAD MED SCI,BEIJING,PEOPLES R CHINA
[2] BEIJING UNION MED COLL,BEIJING,PEOPLES R CHINA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1997年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：T548 / T548
页数：1
相关论文
共 50 条
  • [41] BONE MARKERS IN POSTMENOPAUSAL OSTEOPOROSIS WOMEN WITH DIABETES
    Hwang, J. -S.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S96 - S96
  • [42] The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women
    Sun, Tao
    Chen, Mingqi
    Lin, Xiaoyan
    Yu, Ruixiang
    Zhao, Yong
    Wang, Jianhang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 22 (01) : 200 - 203
  • [43] EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    ADAMI, S
    PASSERI, M
    ORTOLANI, S
    BROGGINI, M
    CARRATELLI, L
    CARUSO, I
    GANDOLINI, G
    GNESSI, L
    LAURENZI, M
    LOMBARDI, A
    NORBIATO, G
    PRYORTILLOTSON, S
    REDA, C
    ROMANINI, L
    SUBRIZI, D
    WEI, L
    YATES, AJ
    BONE, 1995, 17 (04) : 383 - 390
  • [44] 3-YEAR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH ORAL ALENDRONATE - EFFECTS ON BONE MASS AND TURNOVER AND SAFETY
    DOWNS, R
    BAKER, M
    BELL, N
    EMKEY, R
    TONINO, R
    TUCCI, J
    WEISS, S
    PEVERLY, C
    KHER, U
    SANTORA, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S139 - S139
  • [45] Five-year treatment of osteoporosis in postmenopausal women with oral alendronate: Effects on bone mass and turnover and safety
    Favus, M
    Emkey, R
    Leite, M
    Devogelaer, JP
    Rodriguez, J
    Peverly, C
    Kaur, A
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : 189 - 189
  • [46] SUPERIOR EFFECTS OF STRONTIUM RANELATE COMPARED TO ALENDRONATE ON BONE MASS AND STRENGTH PARAMETERS AT THE TIBIA IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Felsenberg, Dieter
    Brandi, Maria Luisa
    Sergi, Giuseppe
    Bergstrom, Ingrid
    Beller, Gisela
    Fiore, Carmelo
    Lyritis, George
    Kindmark, Andreas
    Boerst, Hendrikje
    Bock, Oliver
    Hartard, Manfred
    Runge, Martin
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 102 - 102
  • [47] Reproductive factors, body mass index and bone mass in healthy Chinese postmenopausal women
    Fan, J
    Xie, B
    Jia, JB
    Lin, Y
    Zhao, XH
    FASEB JOURNAL, 2002, 16 (04): : A376 - A376
  • [48] Influence of lean and fat mass on bone mineral density (BMD) in postmenopausal women with osteoporosis
    Dytfeld, Joanna
    Ignaszak-Szczepaniak, Magdalena
    Gowin, Ewelina
    Michalak, Michal
    Horst-Sikorska, Wanda
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2011, 53 (02) : E237 - E242
  • [49] Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene
    Powles, Trevor J.
    Diem, Susan J.
    Fabian, Carol J.
    Neven, Patrick
    Wickerham, D. Lawrence
    Cox, David A.
    Muram, David
    Agnusdei, Donato
    Dowsett, Sherie A.
    Amewou-Atisso, Messan
    Cummings, Steven R.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 299 - 306
  • [50] Postmenopausal women with minimal trauma fractures are unapprised of the existence of low bone mass or osteoporosis
    Edwards, BJ
    Iris, M
    Ferkel, E
    Feinglass, J
    MATURITAS, 2006, 53 (03) : 260 - 266
12345